1-2 of 2
John M. Fidler, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRx102, a Novel Triptolide Analogue, Has Low Nanomolar Activity Against AML Stem/Progenitor Cells in Vitro and in a Murine Model of AML

Bing Z Carter, Ph.D., Duncan H Mak, M.S., Yuxie Shi, John M. Fidler, Ph.D., Rong Chen, PhD, Xiaoyang Ling, PhD, William Plunkett, PhD, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 1547.
https://doi.org/10.1182/blood.V118.21.1547.1547
Published: 2011
Journal Articles

Preclinical Development of Triptolide Derivative MRx102 as a Therapeutic Agent for Acute Myeloid Leukemia

John M. Fidler, Ph.D., Jinhua An, Ph.D., John H. Musser, Ph.D., Duncan H. Mak, M.S., Bing Carter, Ph.D., Michael Andreeff, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3271.
https://doi.org/10.1182/blood.V116.21.3271.3271
Published: 2010